J.L.S. has received funding from various organizations such as the Juvenile Diabetes Research Foundation (JDRF), National Institute of Diabetes and Digestive and Kidney Diseases, Jaeb Center for Health Research, Insulet, Medtronic, Provention Bio, and Abbott, all paid to her institution. She also serves as a consultant for Abbott, Insulet, Medtronic Diabetes, and Zealand Pharma. Additionally, she reports owning stock/stock options in StartUp Health T1D Moonshot. On the other hand, L.M.N. has received research funding from the National Institutes of Health (NIH) and Medtronic Diabetes which was paid to her institution. She also serves as a consultant for WebMD and Calm.
Both authors disclose their competing interests in this content:
J.L.S.: I have received grants or contracts from various organizations such as the Juvenile Diabetes Research Foundation (JDRF), National Institute of Diabetes and Digestive and Kidney Diseases, Jaeb Center for Health Research, Insulet, Medtronic, Provention Bio, and Abbott, all paid to my institution.
I have also received consulting fees from Abbott and payment or honoraria from Insulet, Medtronic Diabetes and Zealand Pharma.
I participate in advisory boards for Cecelia Health, Insulet Mannkind Medical Devices Inc., Medtronic Diabetes Inc., Vertex Pharmaceuticals Inc.
Finally I report owning stock/stock options in StartUp Health T1D Moonshot.
L.M.N.: I have received research funding from the National Institutes of Health (NIH) and Medtronic Diabetes which was paid to my institution.
I also serve as a consultant for WebMD and Calm.
